Pacira Pharmaceuticals, Inc. Announces Grants Of Inducement Stock Options Under NASDAQ Listing Rule 5635(c)(4)

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that on April 15, 2014, it approved the grant of stock options to 17 new employees to purchase an aggregate of 81,000 shares of common stock. The stock options were granted as inducements material to the new employees entering into employment with Pacira, as permitted under NASDAQ Listing Rule 5635(c)(4).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC